Our History
Our History
Key milestones since LinkedBio’s founding in 2021.
2021. 05
First Partnership Agreement
Commenced collaboration on a B-cell lymphoma development program
2021. 12
First IND Approval
Successfully secured IND approval — 9 programs approved to date
2022. 01
Advanced Biologics LTFU Collaboration
Initiated first long-term follow-up (LTFU) collaboration for an advanced biologic therapy program
2022. 06
MFDS Inspection Support
Began regulatory inspection support from Korea’s Ministry of Food and Drug Safety (MFDS) for product approval
Beyond
Expanding Partnership Network
Signed MOUs and expanded collaborative partnerships with EveryH, Q&Vis, MediPlexus, MediInsight, BioMarketingLab, and other organizations